Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu And Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Thr-Gly

1 trials NNeurology/Psychiatry Orphan designation

Filter these 1 trials by condition, phase, country and more.

Open in Search →
1 Registered trials
0 Recruiting
1 Completed trials
1 Sponsors
5 Countries
Phase III: 1

Sponsors using this IMP

Sellas Life Sciences Group Inc. 1

All trials

1 total

Showing 1–1 of 1 trials

← All drugs A–Z